Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19)
- DOI
- 10.3390/vaccines11101535
- Published
- 2023-09-28
- Container
- Vaccines
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/vaccines11101535,
title = {Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19)},
author = {Hironori Nakagami and Tetsuya Matsumoto and Kenji Takazawa and Hisakuni Sekino and Osamu Matsuoka and Satoshi Inoue and Hidetoshi Furuie and Ryuichi Morishita},
year = {2023},
journal = {Vaccines},
doi = {10.3390/vaccines11101535},
url = {https://doi.org/10.3390/vaccines11101535}
}RIS
TY - JOUR TI - Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19) AU - Hironori Nakagami AU - Tetsuya Matsumoto AU - Kenji Takazawa AU - Hisakuni Sekino AU - Osamu Matsuoka AU - Satoshi Inoue AU - Hidetoshi Furuie AU - Ryuichi Morishita PY - 2023 JO - Vaccines DO - 10.3390/vaccines11101535 UR - https://doi.org/10.3390/vaccines11101535 ER -
APA
Nakagami, H., Matsumoto, T., Takazawa, K., Sekino, H., Matsuoka, O., Inoue, S., Furuie, H., & Morishita, R. (2023). Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19). Vaccines. https://doi.org/10.3390/vaccines11101535
Source records
- crossref · retrieved 2026-09-26T05:46:00.164Z